CBDP, also known as Cannabidiphorol CBD-heptyl or CBD-C7, is a relatively new cannabinoid that has been discovered in the cannabis plant. It shows great potential for its possible health benefits and is currently being studied for its therapeutic properties.
Chemical name: Cannabidiphorol CBD-heptyl
Molecular formula: C23H38O2
Formula weight: 346.55 g/mol
CAS No: 55824-13-0
Top ten keywords from Google and Synonyms:
Synonyms: CBD-C7, Cannabidiol-heptyl, Heptylcannabidiol, Cannabidiol-7-heptyl, C7-CBD
Health benefits of this product: Like other cannabinoids, CBDP has been found to have a variety of potential health benefits. These include:
Anti-inflammatory properties: CBDP may help reduce inflammation in the body, which can be beneficial for individuals with conditions such as arthritis, inflammatory bowel disease, and asthma.
Pain relief: CBDP may have analgesic effects, meaning it could help reduce pain levels.
Anti-anxiety properties: CBDP may help reduce anxiety levels in some individuals.
Neuroprotective properties: CBDP may have neuroprotective properties, which means it could help protect the brain from damage caused by injury or disease.
Antioxidant properties: Like other cannabinoids, CBDP has antioxidant properties, which means it can help protect cells from oxidative stress and damage.
Potential effects: While research on CBDP is still in its early stages, some potential effects based on current studies include:
Reduced inflammation: CBDP has been shown to reduce inflammation in animal models.
Anti-cancer properties: Some research suggests that CBDP may have anti-cancer properties, although more studies are needed to confirm this.
Improved gut health: CBDP may have beneficial effects on the gut microbiome, potentially improving digestive health.
Product mechanism: CBDP works by interacting with the body's endocannabinoid system (ECS). The ECS is a network of receptors and enzymes that helps regulate various physiological processes, including inflammation, pain, mood, and appetite. CBDP binds to CB1 and CB2 receptors in the ECS, which can modulate these processes and potentially provide therapeutic benefits.
Safety: CBDP appears to be safe for most people when taken in appropriate doses. However, like all cannabinoids, it may cause side effects in some individuals.
Side effects: The most common side effects of CBDP include dry mouth, dizziness, and fatigue. In rare cases, it may also cause nausea, vomiting, or diarrhea. Individuals who are pregnant or breastfeeding should avoid using CBDP, as there is currently not enough research to determine its safety in these populations.
Dosing information: There is currently no standard dosing recommendation for CBDP, as research is still ongoing. However, most studies use doses ranging from 2-100 mg/kg of body weight. It is important to talk to a healthcare provider before using CBDP, especially if you have a medical condition or are taking medication.
Conclusion: CBDP is a promising cannabinoid with a range of potential health benefits. While more research is needed to fully understand its therapeutic potential, early studies suggest that it may be useful for reducing inflammation, protecting the brain, and relieving pain. As with all cannabinoids, it is important to use CBDP safely and responsibly, under the guidance of a healthcare professional
